A phase IV, observational, practice based, open label, non-comparative, multicenter study to evaluate the safety, tolerability and efficacy of biosimilar of Etanercept in India.

Trial Profile

A phase IV, observational, practice based, open label, non-comparative, multicenter study to evaluate the safety, tolerability and efficacy of biosimilar of Etanercept in India.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Dec 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis; Juvenile rheumatoid arthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Cipla
  • Most Recent Events

    • 13 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top